Cargando…

Plasmacytoma of the Skull-base: A Rare Tumor

Plasmacytoma of the skull-base is a rare entity. Differential diagnosis includes chordoma, osteosarcoma, carcinoma nasopharynx, meningioma, metastatic carcinoma, lymphoma, and multiple myeloma. Accurate and precise diagnosis is extremely important for plasmacytoma of the skull-base as its treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Siyag, Abhilasha, Soni, Tej P, Gupta, Anil K, Sharma, Lalit M, Jakhotia, Naresh, Sharma, Shantanu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854301/
https://www.ncbi.nlm.nih.gov/pubmed/29552435
http://dx.doi.org/10.7759/cureus.2073
_version_ 1783306888850440192
author Siyag, Abhilasha
Soni, Tej P
Gupta, Anil K
Sharma, Lalit M
Jakhotia, Naresh
Sharma, Shantanu
author_facet Siyag, Abhilasha
Soni, Tej P
Gupta, Anil K
Sharma, Lalit M
Jakhotia, Naresh
Sharma, Shantanu
author_sort Siyag, Abhilasha
collection PubMed
description Plasmacytoma of the skull-base is a rare entity. Differential diagnosis includes chordoma, osteosarcoma, carcinoma nasopharynx, meningioma, metastatic carcinoma, lymphoma, and multiple myeloma. Accurate and precise diagnosis is extremely important for plasmacytoma of the skull-base as its treatment and prognosis is different from other skull-base lesions. A 41-year-old man presented with concerns of headache, diplopia, and left eye strabismus. A magnetic resonance image (MRI) of his brain showed a large expansile mass measuring 51 mm involving the clivus and central skull-base. Trans-sphenoidal tumor decompression was done. A biopsy confirmed the plasmacytoma. A positron emission tomography-computed tomography (PET-CT) scan showed a single 2-(18F) fluoro-D-glucose (FDG) avid lesion at the skull-base. The results of all other relevant investigations such as hemoglobin, renal function test, serum calcium, serum protein immunoelectrophoresis, serum quantitative immunoglobulin, bone marrow biopsy, serum lactate dehydrogenase, and beta-2 microglobulin levels were within normal limits. He was treated with radical radiotherapy. He developed complete clinical response after radiotherapy.
format Online
Article
Text
id pubmed-5854301
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-58543012018-03-16 Plasmacytoma of the Skull-base: A Rare Tumor Siyag, Abhilasha Soni, Tej P Gupta, Anil K Sharma, Lalit M Jakhotia, Naresh Sharma, Shantanu Cureus Radiation Oncology Plasmacytoma of the skull-base is a rare entity. Differential diagnosis includes chordoma, osteosarcoma, carcinoma nasopharynx, meningioma, metastatic carcinoma, lymphoma, and multiple myeloma. Accurate and precise diagnosis is extremely important for plasmacytoma of the skull-base as its treatment and prognosis is different from other skull-base lesions. A 41-year-old man presented with concerns of headache, diplopia, and left eye strabismus. A magnetic resonance image (MRI) of his brain showed a large expansile mass measuring 51 mm involving the clivus and central skull-base. Trans-sphenoidal tumor decompression was done. A biopsy confirmed the plasmacytoma. A positron emission tomography-computed tomography (PET-CT) scan showed a single 2-(18F) fluoro-D-glucose (FDG) avid lesion at the skull-base. The results of all other relevant investigations such as hemoglobin, renal function test, serum calcium, serum protein immunoelectrophoresis, serum quantitative immunoglobulin, bone marrow biopsy, serum lactate dehydrogenase, and beta-2 microglobulin levels were within normal limits. He was treated with radical radiotherapy. He developed complete clinical response after radiotherapy. Cureus 2018-01-15 /pmc/articles/PMC5854301/ /pubmed/29552435 http://dx.doi.org/10.7759/cureus.2073 Text en Copyright © 2018, Siyag et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Radiation Oncology
Siyag, Abhilasha
Soni, Tej P
Gupta, Anil K
Sharma, Lalit M
Jakhotia, Naresh
Sharma, Shantanu
Plasmacytoma of the Skull-base: A Rare Tumor
title Plasmacytoma of the Skull-base: A Rare Tumor
title_full Plasmacytoma of the Skull-base: A Rare Tumor
title_fullStr Plasmacytoma of the Skull-base: A Rare Tumor
title_full_unstemmed Plasmacytoma of the Skull-base: A Rare Tumor
title_short Plasmacytoma of the Skull-base: A Rare Tumor
title_sort plasmacytoma of the skull-base: a rare tumor
topic Radiation Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854301/
https://www.ncbi.nlm.nih.gov/pubmed/29552435
http://dx.doi.org/10.7759/cureus.2073
work_keys_str_mv AT siyagabhilasha plasmacytomaoftheskullbaseararetumor
AT sonitejp plasmacytomaoftheskullbaseararetumor
AT guptaanilk plasmacytomaoftheskullbaseararetumor
AT sharmalalitm plasmacytomaoftheskullbaseararetumor
AT jakhotianaresh plasmacytomaoftheskullbaseararetumor
AT sharmashantanu plasmacytomaoftheskullbaseararetumor